Cough News and Research RSS Feed - Cough News and Research

New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma. [More]
Study explains long-term pulmonary outcomes among childhood cancer survivors

Study explains long-term pulmonary outcomes among childhood cancer survivors

A team of researchers from nine leading academic hospitals and research centers have published a paper in the early online edition of the journal Cancer that describes pulmonary outcomes among childhood cancer survivors. [More]
New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office. [More]
Valley fever diagnosis often overlooked by primary care physicians

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection. [More]
Testing lung health online: an interview with Professor Stephen Holgate

Testing lung health online: an interview with Professor Stephen Holgate

In our latest report – The Battle for Breath – the impact of lung disease in the UK, figures suggest that 1 in 5 (around 12.7 million) have been diagnosed with a lung condition in the UK. If you’re over the age of 70, this rises to 1 in 3. [More]
Exposure to infections in early life not linked to higher mortality risk during adulthood

Exposure to infections in early life not linked to higher mortality risk during adulthood

A new biological study by the University of Stirling has found that exposure to infections in early life does not have long-lasting consequences for later-life survival and reproduction. [More]
New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Researchers develop new technique to help GPs better diagnose UTI in children

Researchers develop new technique to help GPs better diagnose UTI in children

Urinary tract infections (UTI) in young children can lead to kidney damage, but are notoriously difficult to diagnose in primary care because symptoms can often be vague and unclear. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
British Lung Foundation launches exhibition at the houses of parliament

British Lung Foundation launches exhibition at the houses of parliament

A week-long parliamentary exhibition is being held by the British Lung Foundation (BLF) in the Upper Waiting Hall at the houses of parliament from 4-8 July. [More]
Simple 7-item screening device can help detect patients at risk for COPD

Simple 7-item screening device can help detect patients at risk for COPD

A simple 7-item screening tool can help clinicians identify patients at risk for chronic obstructive pulmonary disease (COPD), even if they are not experiencing any symptoms. [More]
Alcohol intoxication perturbs immune system of aged individuals

Alcohol intoxication perturbs immune system of aged individuals

The immune system in the elderly is dysfunctional and infections are more prevalent, more severe, and harder to defeat. Drinking alcohol has a variety of damaging effects on the immune system and organs - like the gut, liver and lung - which can be worsened by pre-existing conditions as well as consumption of prescription and over-the-counter medications that aged individuals often take. [More]
Clinical trial to test efficacy of new drug for chronic cough

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist. [More]
Younger patients more likely to be diagnosed with late stage lung cancer than older adults, say researchers

Younger patients more likely to be diagnosed with late stage lung cancer than older adults, say researchers

Younger patients - aged 50 to 64 - are more likely to be diagnosed with late stage lung cancer than older patients according to new data being presented at the Cancer Outcomes and Data Conference in Manchester today (Tuesday). [More]
New research explores women’s perspective about medication use during pregnancy

New research explores women’s perspective about medication use during pregnancy

Pregnant women overestimate the risks of taking over the counter and prescribed medication - according to new research from the University of East Anglia. [More]
FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients. [More]
Researchers find Aspergillus as interesting target for discovery of novel drugs

Researchers find Aspergillus as interesting target for discovery of novel drugs

The fungus Aspergillus fumigatus produces a group of previously unknown natural products. With reference to plant isoquinoline alkaloids, these substances have been named fumisoquins. [More]
MERS individuals develop severe critical illness, higher mortality than non-MERS SARI patients

MERS individuals develop severe critical illness, higher mortality than non-MERS SARI patients

Patients with Middle East Respiratory Syndrome (MERS) develop more severe critical illness and have higher mortality than patients with non-MERS severe acute respiratory infection (SARI), according to investigators involved with the largest study of critically ill patients with MERS. [More]
Single sputum sample approach to TB diagnosis provides rapid, accurate results

Single sputum sample approach to TB diagnosis provides rapid, accurate results

A streamlined approach to tuberculosis (TB) diagnosis requiring a single sputum sample and providing rapid, accurate results to patients proved feasible in rural Uganda, according to research presented at the ATS 2016 International Conference. [More]
Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States. [More]
Advertisement
Advertisement